title: Alternative polyadenylation and miR-34 family members regulate tau expression.
abstract: Tau pathologically aggregates in Alzheimer's disease, and evidence suggests that reducing tau expression may be safe and beneficial for the prevention or treatment of this disease. We sought to examine the role of the 3'-untranslated region (3'-UTR) of human tau mRNA in regulating tau expression. Tau expresses two 3'-UTR isoforms, long and short, as a result of alternative polyadenylation. Using luciferase reporter constructs, we found that expression from these isoforms is differentially controlled in human neuroblastoma cell lines M17D and SH-SY5Y. Several microRNAs were computationally identified as candidates that might bind the long, but not short, tau 3'-UTR isoform. A hit from a screen of candidates, miR-34a, was subsequently shown to repress the expression of endogenous tau protein in M17D cells. Conversely, inhibition of endogenously expressed miR-34 family members leads to increased endogenous tau expression. In addition, through an unbiased screen of fragments of the human tau 3'-UTR using a luciferase reporter assay, we identified several other regions in the long tau 3'-UTR isoform that contain regulatory cis-elements. Improved understanding of the regulation of tau expression by its 3'-UTR may ultimately lead to the development of novel therapeutic strategies for the treatment of Alzheimer's disease and other tauopathies. mRNA 3'-untranslated regions (3'-UTR) often regulate transcript stability or translation. Despite the centrality of the tau protein in Alzheimer's and other neurodegenerative diseases, the human tau 3'-UTR has been little studied. This report identifies regions of the tau 3'-UTR that influence expression and shows that microRNA (miR)-34a targets this 3'-UTR to lower expression, which is considered an important therapeutic goal.
authors.affiliation: Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: John R
authors.initials: JR
authors.lastname: Dickson
authors.forename: Carla
authors.initials: C
authors.lastname: Kruse
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Montagna
authors.forename: Bente
authors.initials: B
authors.lastname: Finsen
authors.forename: Michael S
authors.initials: MS
authors.lastname: Wolfe
mesh_terms: D020413:3' Untranslated Regions; D001483:Base Sequence; D002478:Cells, Cultured; D005786:Gene Expression Regulation; D006801:Humans; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D008969:Molecular Sequence Data; D026723:Polyadenylation; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D016875:tau Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D020413:3' Untranslated Regions; C522425:MIRN34 microRNA, human; D035683:MicroRNAs; D020033:Protein Isoforms; D016875:tau Proteins
keywords: 3′-untranslated region; Alzheimer's disease; MAPT; gene regulation; neurodegenerative disease
references.citation: Annu Rev Neurosci. 2001;24:1121-59
references.pmid: 11520930
references.citation: J Neurosci. 2001 Sep 1;21(17):6577-87
references.pmid: 11517247
references.citation: J Biochem. 1986 May;99(5):1541-4
references.pmid: 2423512
references.citation: Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21099-104
references.pmid: 22160706
references.citation: PLoS One. 2011;6(8):e21396
references.pmid: 21857907
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7737-41
references.pmid: 9636220
references.citation: Int J Oncol. 2011 May;38(5):1189-95
references.pmid: 21399872
references.citation: Curr Genomics. 2009 May;10(3):154-68
references.pmid: 19881909
references.citation: Curr Biol. 2007 Aug 7;17(15):1298-307
references.pmid: 17656095
references.citation: J Neurosci. 1999 Aug 15;19(16):6907-17
references.pmid: 10436048
references.citation: Cell. 2010 Aug 6;142(3):387-97
references.pmid: 20655099
references.citation: Cell Mol Life Sci. 2012 Nov;69(21):3613-34
references.pmid: 22538991
references.citation: Nat Genet. 2005 May;37(5):495-500
references.pmid: 15806104
references.citation: Proc Natl Acad Sci U S A. 1988 Jun;85(11):4051-5
references.pmid: 3131773
references.citation: Ann Neurol. 1998 Jun;43(6):815-25
references.pmid: 9629852
references.citation: J Neurosci Res. 2007 Jan;85(1):173-83
references.pmid: 17086542
references.citation: Science. 2010 Oct 8;330(6001):198
references.pmid: 20829454
references.citation: Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21093-8
references.pmid: 22160687
references.citation: Nucleic Acids Res. 2012 Sep 1;40(17):8460-71
references.pmid: 22753024
references.citation: Bioinformatics. 2007 Nov 1;23(21):2947-8
references.pmid: 17846036
references.citation: Proc Natl Acad Sci U S A. 1986 Jun;83(11):4040-3
references.pmid: 2424015
references.citation: FASEB J. 2004 Nov;18(14):1761-3
references.pmid: 15364895
references.citation: J Cell Biol. 1993 Apr;121(2):257-67
references.pmid: 8468346
references.citation: Nucleic Acids Res. 2008 Jan;36(Database issue):D149-53
references.pmid: 18158296
references.citation: Gene Regul Syst Bio. 2007 Dec 20;1:263-74
references.pmid: 19936094
references.citation: Science. 1992 Apr 10;256(5054):184-5
references.pmid: 1566067
references.citation: Int J Dev Neurosci. 1995 Apr;13(2):113-27
references.pmid: 7639096
references.citation: Nucleic Acids Res. 2009 Jul;37(Web Server issue):W273-6
references.pmid: 19406924
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6
references.pmid: 18755897
references.citation: J Cell Biol. 1986 Dec;103(6 Pt 2):2739-46
references.pmid: 3098742
references.citation: PLoS One. 2011;6(7):e22391
references.pmid: 21799842
references.citation: Mamm Genome. 2001 Sep;12(9):700-12
references.pmid: 11641718
references.citation: RNA. 2012 Dec;18(12):2105-17
references.pmid: 23097429
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6364-9
references.pmid: 11959919
references.citation: Proc Natl Acad Sci U S A. 1986 Jun;83(11):4044-8
references.pmid: 2424016
references.citation: J Neurochem. 2000 Sep;75(3):991-1003
references.pmid: 10936180
references.citation: Cell. 2005 Jan 14;120(1):15-20
references.pmid: 15652477
references.citation: Nature. 1998 Jun 18;393(6686):702-5
references.pmid: 9641683
references.citation: Hum Genet. 2006 Aug;120(1):1-21
references.pmid: 16645853
references.citation: Science. 2007 May 4;316(5825):750-4
references.pmid: 17478722
references.citation: Proc Natl Acad Sci U S A. 1975 May;72(5):1858-62
references.pmid: 1057175
references.citation: Cell. 2004 Jan 23;116(2):281-97
references.pmid: 14744438
references.citation: Cancer Chemother Pharmacol. 2013 May;71(5):1159-71
references.pmid: 23423488
references.citation: J Mol Neurosci. 1999 Apr;12(2):131-45
references.pmid: 10527457
references.citation: J Alzheimers Dis. 2008 May;14(1):27-41
references.pmid: 18525125